Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 25 , ISSUE S2 ( May, 2021 ) > List of Articles


Dengue and Other Viral Hemorrhagic Fevers

Prakash Shastri, Saurabh Taneja

Citation Information :

DOI: 10.5005/jp-journals-10071-23814

License: CC BY-NC 4.0

Published Online: 01-05-2021

Copyright Statement:  Copyright © 2021; The Author(s).


  1. Marty AM, Jahrling PB, Geisbert TW. Viral hemorrhagic fevers. Clin Lab Med 2006;26:345–386. DOI: 10.1016/j.cll.2006.05.001.
  2. Hidalgo J, Richards GA, Jiménez JIS, Baker T, Amin P. Viral haemorrhagic fever in the tropics: report from the task force on tropical diseases by the World Federation of Societies of Intensive and Critical Care Medicine. J Crit Care 2017;42:366–372. DOI: 10.1016/j.jcrc.2017.11.006.
  3. World Health Organization (WHO) Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever revised and expanded Ed. New Delhi: WHO South East Asia Regional Office; 2011.
  4. Dengue: guidelines for diagnosis, treatment, prevention, and control, New ed. Geneva: TDR/World Health Organization; 2009.
  5. Pang J, Leo YS, Lye DC. Critical care for dengue in adult patients: an overview of current knowledge and future challenges. Curr Opin Crit Care 2016;22:485–490. DOI: 10.1097/MCC.0000000000000339.
  6. Grange L, Simon-Loriere E, Sakuntabhai A, Gresh L, Paul R. Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Front Immunol 2014;5:280. DOI: 10.3389/fimmu.2014.00280.
  7. Hart CA, Bennett M. Hantavirus infections: epidemiology and pathogenesis. Microbes Infect 1999;14:1229–1237. DOI: 10.1016/s1286-4579(99)00238-5.
  8. Bi Z, Formenty PB, Roth CE. Hantavirus infection: a review and global update. J Infect Dev Ctries 2008;2:3–23. DOI: 10.3855/jidc.317.
  9. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, et al. Placebo controlled, double-blind trial of intravenous ribavirin for the treatment of hanta virus cardiopulmonary syndrome in North America. Clin Infect Dis 2004;39:1307–1313. DOI: 10.1086/425007.
  10. Jacob ST, Crozier I, Fischer WA, Hewlett A, Kraft CS, de La Vega M-A, et al. Ebola virus disease. Nat Rev Dis Primers 2020;6:13. DOI: 10.1038/s41572-020-0147-3.
  11. Centers for Disease Control and Prevention. Case definition for Ebola virus disease (EVD). 2014. Available from: Accessed 14 March 2021.
  12. Stephen BK, Bolay F, Kieh M, Grandits G, Badio M, Ballou R, et al. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 2017;377:1438–1447. DOI: 10.1056/NEJMoa1614067.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.